Why the study?
Radiotherapy-associated cardiovascular disease is a concern in breast cancer survivors, prompting evaluation of the dosimetric benefit of DIBH and pre-treatment predictors of cardiac doses to guide patient selection.
Does Deep Inspiratory Breath-hold technique (DIBH) reduce cardiac radiation doses compared to Free Breathing in patients with left-sided breast cancer undergoing radiotherapy?
Does Deep Inspiratory Breath-hold technique (DIBH) reduce cardiac radiation doses compared to Free Breathing in patients with left-sided breast cancer undergoing radiotherapy?
DIBH significantly reduces radiation doses to the heart and lungs in left-sided breast cancer patients, with reductions in Heart Volume in Field and Maximum Heart Depth serving as predictors for cardiac sparing.
Answers are grounded in this paper and cite their sources.
DIBH associated with lower cardiac doses; hypothesis-generating, needs randomized confirmation before practice change.
INTRODUCTION: The risk of radiotherapy-associated cardiovascular disease has been a concern for decades in breast cancer survivors. The objective of our study is to evaluate the dosimetric benefit of Deep Inspiratory Breath-hold technique (DIBH) on organs-at-risk (OAR) sparing in left-sided breast cancer radiotherapy and to find out pre-treatment predictors of cardiac doses for guiding patient selection for DIBH. MATERIAL AND METHODS: test and correlation was evaluated using Pearson correlation. Linear regression was used to get independent predictors of cardiac sparing and Receiver Operating Characteristic (ROC) curve analysis was done to find out the specific threshold of the predictors. RESULTS: There was a 39.15% reduction in mean heart dose in DIBH compared to FB (2.4 Gy vs 4.01 Gy) (p < 0.001), 19% reduction in maximum Left Anterior Descending (LAD) dose and a 9.9% reduction in ipsilateral lung mean dose (p = 0.036) with DIBH. A significant correlation was observed between reduction in Heart Volume in Field (HVIF) and Maximum Heart Depth (MHD) with reduction in mean heart dose. Reduction in HVIF (ΔHVIF) independently predicted cardiac sparing. CONCLUSION: DIBH leads to significant reduction in OAR doses and is suggested for all patients of left-sided breast cancer undergoing radiotherapy. However, HVIF and MHD predicted for cardiac sparing and threshold criteria of ΔHVIF and ΔMHD may be used by centres with high workload to select patients for DIBH.
No takes yet. Share an insight, caveat, or question.
Ferdinand et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: